409. Therapeutic Efficacy of Oncolytic Herpes Virus and Chemotherapy for Treatment of Late-Stage Ovarian Cancer

Molecular Therapy- United States

doi 10.1016/s1525-0016(16)34744-x

Full Text

Abstract

Available in

Date

Authors

Unknown

Publisher

Elsevier BV

Related search

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

2005English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 With Integrin Β1 Blocking Antibody OS2966

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer

2004English

Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic

Cancer Research
Cancer ResearchOncology
2010English

Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

Comparison of Safety, Delivery, and Efficacy of Two Oncolytic Herpes Viruses (G207 and NV1020) for Peritoneal Cancer

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy